Rick E. Winningham - 15 Mar 2024 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
19 Mar 2024, 18:06:26 UTC
Prior SEC filing
22 Feb 2024
Next SEC filing
04 Apr 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Rick E. Winningham

Key filing fact

Rick E. Winningham filed Form 4 for Theravance Biopharma, Inc. (TBPH) on 19 Mar 2024.

Key facts

  • This page summarizes Rick E. Winningham's Form 4 filing for Theravance Biopharma, Inc. (TBPH).
  • 4 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 19 Mar 2024, 18:06.

Change

  • Previous filing in this sequence was filed on 22 Feb 2024.
  • Current net transaction value: +$23,363.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TBPH transaction

Ordinary Shares

Award

Transaction value
$23,363
Shares
+2,704
Change %
+0.17%
Price
$8.64
Shares after
1,561,473
Date
15 Mar 2024
Ownership
Direct
Footnotes
F1
TBPH transaction

Ordinary Shares

Gift

Transaction value
$0
Shares
-7,000
Change %
-0.45%
Price
$0.000000
Shares after
1,554,473
Date
15 Mar 2024
Ownership
Direct
Footnotes
F2
TBPH transaction

Ordinary Shares

Gift

Transaction value
$0
Shares
-3,900
Change %
-0.25%
Price
$0.000000
Shares after
1,550,573
Date
15 Mar 2024
Ownership
Direct
Footnotes
F3
TBPH transaction

Ordinary Shares

Gift

Transaction value
$0
Shares
+3,900
Change %
Price
$0.000000
Shares after
3,900
Date
15 Mar 2024
Ownership
As Custodian
Footnotes
F3, F4
TBPH holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
92,567
Date
15 Mar 2024
Ownership
By Trust
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Reflects an acquisition from the Issuer pursuant to a restricted share purchase agreement under the Issuer's Amended and Restated 2013 Equity Incentive Plan at a per-share price equal to the closing per-share price of the Issuer's ordinary shares on the Nasdaq Global Market on March 15, 2024. Transaction was with the Issuer and did not involve an open market transaction.

Footnote F2

Bona Fide Gift. No compensation was given to the donor for the gifting of shares.

Footnote F3

Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA"), for which the Reporting Person serves as a custodian.

Footnote F4

The shares are held for grandchildren of the Reporting Person through a UTMA account, for which the Reporting Person serves as custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his grandchildren's shares for purposes of Section 16 or for any other purpose.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .